Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and ...

Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in ...

Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will ...

GAAP EPS loss widened to $(1.22) from $(1.10) year over year in Q2 2025 as R&D expenses rose 47.7% and G&A expenses climbed 48.8% compared to Q2 2024. VAX-31 vaccine program advanced with FDA expanded ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

The mRNA vaccines revolutionized pandemic response and are now being explored for cancer and genetic disease treatments, ...

Health-care companies fell as investors continued to retreat from formerly hot areas such as obesity-drug and vaccine makers. Shares of Novo Nordisk continued their slide despite reporting a ...

T he U.S. Department of Health and Human Services (HHS) said on Tuesday that it will start winding down mRNA vaccine development efforts under a federal health agency focused on developing medical ...

This was one in a continuing line of moves that has put RFK Jr.'s vaccine skepticism into public policy, though scientists ...

Moderna's stock fell Wednesday after Health and Human Services Secretary Robert F. Kennedy Jr. said the department was winding down development of mRNA vaccines.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, ...

The Trump administration is terminating biodefense research funding for mRNA projects, raising concerns about the nation’s ...